|
Two recent studies from the UTRGV School of Medicine ST-CECR research team have been selected for cover art in American Chemical Society journals, highlighting the team’s work in cancer nanotechnology, drug delivery and drug repurposing.
The first study, published in ACS Nano Medicine, examines a multifunctional nanoparticle platform designed for pulmonary drug delivery with potential applications in cancer and respiratory infections. The second, published in ACS Omega, explores the potential of repurposing the antifungal medication miconazole as a treatment for prostate cancer and examines its underlying anticancer mechanisms.
The studies were led by Dr. Yallapu’s research team, including Dr. Hanuma Ghali and Dr. Rahul Tiwari, with contributions from Drs. Chauhan, Nguyen, Khan and Dhasmana. The cover-art recognition celebrates the creativity and scientific impact of these collaborative research efforts.
Congratulations!
|